Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: In this review we will provide recommendations for surgical site infection (SSI) prophylaxis in urological diagnostic and surgical procedures.
Material And Methods: We performed a narrative review of the literature in PubMed (Medline), EMBASE, LILACS, Web of Science, and Cochrane Collaboration databases using the terms "infection," "surgery," "urology," and "antibiotic prophylaxis" Results: We suggest recommendations of prophylactic antibiotic in the follow procedures: prostate biopsy, Urethrocystoscopy, Extracorporeal Shock Wave Lithotripsy (ESWL) for Urinary Stones, endoscopic ureterolithotripsy, percutaneous nephrolitothomy, Transurethral Resection of the Prostate (TURP) and Prostatic Enucleation, Transurethral Resection of Bladder Tumor (TURBT), Intravesical Botulinum Toxin Injection, surgical correction of female stress incontinence, Surgical Correction of Pelvic Organ Prolapse, urological prosthesis implantation and Open, Laparoscopic, and Robotic Urologic Surgery Conclusions: Consideration in SSI prophylaxis and the prophylactic antibiotic regimens in several urological procedures are show in this paper and will be useful to urologic practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/S1677-5538.IBJU.2025.0333 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Adverse Effects of Health Plan Prior Authorization on Clinical Effectiveness and Patient Outcomes: A Systematic Review.
Am J Med
September 2025
Russell H. Morgan Department of Radiology and Radiological Science; Department of Oncology; Department of Urology; Johns Hopkins University School of Medicine, Baltimore, MD, Johns Hopkins Health System, Baltimore, MD. Electronic address:
Prior authorization requirements by health insurance plans have become a barrier to healthcare delivery in the United States in terms of clinical efficiency, patient and provider experience. Surveyed physicians report associations with care delays, reduced clinical effectiveness and compromised patient outcomes. In this systematic review, we synthesized the published evidence regarding harmful effects of prior authorization on disease management and patient outcomes.
View Article and Find Full Text PDFIs it prime time for stent-less robotic radical cystectomy? A scoping review.
J Robot Surg
September 2025
Consultant Urological Surgeon, Royal Surrey NHS Foundation Trust, Guildford, UK.
The gold standard treatment for muscle-invasive bladder cancer (MIBC) still is radical cystectomy. Thanks to better peri-operative results than open surgery, robotic-assisted radical cystectomy (RARC) has become somewhat well-known. Though they are linked with problems like infection, pain, and higher healthcare expenses, conventionally ureteral stents are used during urinary diversion to minimize anastomotic leaks and strictures.
View Article and Find Full Text PDFEditorial Comment on "Antibiotic Prophylaxis Before Urodynamics: A Urine Culture-Based Versus Risk-Factors-Based Protocol to Minimize Usage in the Era of Antibiotic Resistance".
Urology
September 2025
Urology, 535 Barnhill Dr. Ste. 420, Indianapolis, IN 46202-5289, United States.
Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025).
J Urol
September 2025
American Urological Association, Linthicum, Maryland.
Purpose: Our perceptions of recurrent UTI (rUTI) have evolved due to additional insights into rUTI pathophysiology, an appreciation for the adverse effects of repetitive antimicrobials ("collateral damage"), rising rates of bacterial antimicrobial resistance, and better reporting of the natural history of localized cystitis and rUTI. This document seeks to guide the evaluation and management of patients with rUTIs to prevent inappropriate antibiotic use, decrease the risk of antibiotic resistance, reduce adverse effects of antibiotics, provide guidance on strategies for rUTI prevention, and improve outcomes and quality of life for women with rUTIs.
Materials And Methods: In 2024, this Guideline was reviewed via the AUA Update Literature Review process, which identified 87 studies for full-text review published between June 1, 2021 and November 1, 2024.
Editorial Comment on "Antibiotic Prophylaxis Is Not Required Before MRI-guided Transperineal Prostate Biopsy".
Urology
September 2025
Department of Urology, University of Washington, Seattle, WA.